Oncogenic suppression of apoptosis uncovers a Rac1/JNK proliferation pathway activated by loss of Par3

Oncogene

Volumn 34, Issue 24, 2015, Pages 3199-3206

  Archibald, A ^a   Mihai, C ^a   MacAra, I G ^b   McCaffrey, L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 3; RAC1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; CELL ADHESION MOLECULE; NEUROPEPTIDE; PARD3 PROTEIN, MOUSE; RAC1 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL CULTURE; CELL POLARITY; CELL TRANSFORMATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; RNA INTERFERENCE; UDDER;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL POLARITY; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DOWN-REGULATION; FEMALE; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; NEUROPEPTIDES; RAC1 GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR;

EID: 84930821197     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.242     Document Type: Article

References (37)

1. McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011; 21: 727-735.
2. Tepass U. The apical polarity protein network in Drosophila epithelial cells: regulation of polarity, junctions, morphogenesis, cell growth, and survival. Annu Rev Cell Dev Biol 2012; 28: 655-685.
3. Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877-883.
4. Huang L, Muthuswamy SK. Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators. Curr Opin Genet Dev 2010; 20: 41-50.
5. Hayase J, Kamakura S, Iwakiri Y, Yamaguchi Y, Izaki T, Ito T et al. The WD40 protein Morg1 facilitates Par6-aPKC binding to Crb3 for apical identity in epithelial cells. J Cell Biol 2013; 200: 635-650.
6. Morais-de-Sa E, Mirouse V, St Johnston D. aPKC phosphorylation of Bazooka defines the apical/lateral border in Drosophila epithelial cells. Cell 2010; 141: 509-523.
7. Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res 2008; 68: 8201-8209.
8. Kim M, Datta A, Brakeman P, Yu W, Mostov KE. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis. J Cell Sci 2007; 120: 2309-2317.
9. Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, Fields AP. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res 2006; 66: 1767-1774.
10. Durgan J, Kaji N, Jin D, Hall A. Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J Biol Chem 2011; 286: 12461-12474.
11. Iden S, van Riel Wilhelmina E, Schäfer R, Song J-Y, Hirose T, Ohno S et al. Tumor type-dependent function of the Par3 polarity protein in skin tumorigenesis. Cancer Cell 2012; 22: 389-403.
12. McCaffrey LM, Macara IG. The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes Dev 2009; 23: 1450-1460.
13. Xue B, Krishnamurthy K, Allred DC, Muthuswamy SK. Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion. Nat Cell Biol 2013; 15: 189-200.
14. Chen X, Macara IG. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat Cell Biol 2005; 7: 262-269.
15. Georgiou M, Baum B. Polarity proteins and Rho GTPases cooperate to spatially organise epithelial actin-based protrusions. J Cell Sci 2010; 123: 1089-1098.
16. Nishimura T, Yamaguchi T, Kato K, Yoshizawa M, Nabeshima Y, Ohno S et al. PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1. Nat Cell Biol 2005; 7: 270-277.
17. Pegtel DM, Ellenbroek SI, Mertens AE, van der Kammen RA, de Rooij J, Collard JG. The Par-Tiam1 complex controls persistent migration by stabilizing microtubuledependent front-rear polarity. Curr Biol 2007; 17: 1623-1634.
18. Zhang H, Macara IG. The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis. Nat Cell Biol 2006; 8: 227-237.
19. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000; 19: 3013-3020.
20. Zhou C, Licciulli S, Avila JL, Cho M, Troutman S, Jiang P et al. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis. Oncogene 2013; 32: 903-909.
21. Kawazu M, Ueno T, Kontani K, Ogita Y, Ando M, Fukumura K et al. Transforming mutations of RAC guanosine triphosphatases in human cancers. Proc Natl Acad Sci USA 2013; 110: 3029-3034.
22. Wertheimer E, Gutierrez-Uzquiza A, Rosemblit C, Lopez-Haber C, Sosa MS, Kazanietz MG. Rac signaling in breast cancer: a tale of GEFs and GAPs. Cell Signal 2012; 24: 353-362.
23. Strumane K, Rygiel T, van der Valk M, Collard JG. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice. J Cancer Res Clin Oncol 2009; 135: 69-80.
24. McCaffrey Luke M, Montalbano J, Mihai C, Macara Ian G. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 2012; 22: 601-614.
25. Hu C, Dievart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 2006; 168: 973-990.
26. Al-Hussaini H, Subramanyam D, Reedijk M, Sridhar SS. Notch signaling pathway as a therapeutic target in breast cancer. Mol Cancer Ther 2011; 10: 9-15.
27. Simmons MJ, Serra R, Hermance N, Kelliher MA. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro. Breast Cancer Res 2012; 14: R126.
28. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8: R76.
29. Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci 2009; 66: 370-374.
30. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004; 101: 7618-7623.
31. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995; 269: 1270-1272.
32. Warner SJ, Yashiro H, Longmore GD. The Cdc42/Par6/aPKC polarity complex regulates apoptosis-induced compensatory proliferation in epithelia. Curr Biol 2010; 20: 677-686.
33. Cellurale C, Girnius N, Jiang F, Cavanagh-Kyros J, Lu S, Garlick DS et al. Role of JNK in mammary gland development and breast cancer. Cancer Res 2012; 72: 472-481.
34. Brumby AM, Richardson HE. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. Embo J 2003; 22: 5769-5779.
35. Uhlirova M, Jasper H, Bohmann D. Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci USA 2005; 102: 13123-13128.
36. Fereshteh MP, Tilli MT, Kim SE, Xu J, O'Malley BW, Wellstein A et al. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res 2008; 68: 3697-3706.
37. Han JS, Crowe DL. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer. Anticancer Res 2010; 30: 3407-3412.